baber/WOPTO huggingface dataset:
Patent FI-961412-A0 (FI)
Inventor: MERCE-VIDAL RAMON
IPC: C07D521/00
Filed: 1996-03-28
Abstract: The present invention relates to the compounds of general formulaused as medicaments possessing therapeutic activity for the treatment of anxiety, psychosis, epilepsy, convulsion, motoricity problems, amnesia, cerebrovascular diseases or senile dementia.
Patent FI-963099-A0 (FI)
Inventor: LYGREN EIVIND
IPC: C02F3/20
Filed: 1996-08-06
Abstract: PCT No. PCT/NO95/00027 Sec. 371 Date Sep. 26, 1996 Sec. 102(e) Date Sep. 26, 1996 PCT Filed Feb. 6, 1995 PCT Pub. No. WO95/21134 PCT Pub. Date Aug. 10, 1995Water to be treated is introduced into a basin having a closed bottom and an outer wall. A stationary diffusor is located at the bottom at a position spaced from the outer wall and produces air bubbles of varying size acting to lift water impurities toward the surface of the water and to circulate the water in the basin as a first stream flowing vertically upwardly from the diffusor, horizontally outwardly toward the outer wall, vertically downwardly toward the bottom and horizontally along the bottom back to the diffusor. A second stream is caused to circulate circumferentially in the basin. The first and second circulating streams cooperate to cause foam and slurry formed on the surface to concentrate in an outer peripheral flow path from which the foam and slurry are removed.
Patent FI-970984-A0 (FI)
Inventor: HAMMOND TIMOTHY
IPC: C08K5/13
Filed: 1997-03-07
Abstract: PCT No. PCT/GB95/02150 Sec. 371 Date Jun. 16, 1997 Sec. 102(e) Date Jun. 16, 1997 PCT Filed Sep. 8, 1995 PCT Pub. No. WO96/07697 PCT Pub. Date Mar. 14, 1996A polymer composition comprises (a) a stereospecific, preferably fermentation derived, polyester of molecular weight Mw over 100000 consisting of repeating units of formula -O-CmHn-CO- in which n=2m and units with m=3 and m=4 with respectively a C1 and C2 side group on the carbon atom next to oxygen in the polymer chain are copolymerised together, m being 3 in 70-95 mol percent of such units; and (b) at least one alkyl phenol in which the alkyl group preferably contains at least one tertiary carbon atom adjacent to or within 4 carbon atoms of the phenol nucleus. The alkyl phenol may be hindered and may contain a C1-6 alkoxy group para to the phenolic hydroxy group. Suitable alkyl phenols include 2-tert-butyl-4-hydroxy-anisole and alpha- or delta- tocopherol and others usable as antioxidants in foods, oils and polymer systems. The polyester and alkyl phenol and relative proportions thereof are preferably chosen to provide inhibition of crystallisation of the polyester corresponding to an Avrami 'k' parameter less than 0.03.
Patent FI-972719-A0 (FI)
Inventor: WINTER RAYMOND GEOFFREY
IPC: C07C69/738
Filed: 1997-06-24
Abstract: PCT No. PCT/GB95/03048 Sec. 371 Date Jun. 25, 1997 Sec. 102(e) Date Jun. 25, 1997 PCT Filed Dec. 29, 1995 PCT Pub. No. WO96/20934 PCT Pub. Date Jul. 11, 1996The invention provides a process for producing lamotrigine of formula (I): which process comprises subjecting a compound of formula (II): wherein R is CN or CONH2, in an organic solvent, to ultra violet or visible radiation and, when R is CN, to heat.
Patent FI-974609-A0 (FI)
Inventor: DIMAIO JOHN
IPC: A61P43/00
Filed: 1997-12-23
Abstract: PCT No. PCT/CA96/00467 Sec. 371 Date Mar. 25, 1998 Sec. 102(e) Date Mar. 25, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/03978 PCT Pub. Date Feb. 6, 1997Polycyclic alkaloids of formula (I), wherein R1 is H, C1-6 alkyl, or C6-12 aryl optionally substituted with polar groups; R2 and R3 are independently H, OH, C1-6 alkyl, -C(NH)-NH2, a positively charged group, or C7-13 aralkyl optionally substituted with NH2, OH, C1-6 alkyl, or halogen; or R2 and R3 together form a 5 to 6 member ring optionally incorporating a heteroatom; R4is H, C1-6 alkyl, OR6, SR6 or N(R6)2, wherein each R6 is independently H, C1-3 alkyl; X is O, S, SO, SO2, N-R5, or C-(R5)2, wherein each R5 is independently H, C1-6 alkyl, or C7-13 aralkyl optionally interrupted with one or more heteroatom; n is an integer from 0 to 2; m is an integer from 0 to 3; with the proviso that when X is CH2 then R1 is not CH3, R2 and R3 are not both H, R4 is not OH, m is not 3 and n is not 0. For the treatment of pain and pharmaceutically acceptable compositions comprising those compounds. The compounds of this invention acts as agonists at the opiate receptor.
Patent IL-63176-A0 (IL)
Title: 2,9-dioxatricyclo (4,3,1,0)decanes and their preparation
IPC: C07D311/94
Filed: 1981-06-25
Abstract: Novel and highly effective sleep inducing 3 beta -hydroxy methyl-4 alpha -hydroxy-8 beta -alkoxy-2,9-dioxa tricyclo [4,3,1,03,7] decane compounds of the following Formula:  <IMAGE>  in which R1 indicates an alkoxy group and preferably a lower alkoxy group, such as the methoxy group, the ethoxy group, or the n-butoxy group, while R2 indicates the 10-methylene group or the 10 beta -methyl group, are produced from didrovaltratum, i.e., 1-isovaleroxy-4-isovaleroxy methyl-7-acetoxy-spiro-oxirano-1,9-dihydrocyclopenta(c)pyrane or from extracts of plants of the genus Valerianaceae which contain about 70% of didrovaltratum. The novel compounds have a surprisingly low toxicity.
Patent IL-63492-A0 (IL)
Title: Process and agent for separating plasma or serum from whole blood
IPC: C12Q1/00
Filed: 1981-08-03
Abstract: A composition and process for permitting the separation of plasma or serum from whole blood. The composition includes glass fibers having an average diameter of from 0.2 mu  to 5 mu  and a density of 0.1 g/cm2 to 0.5 g/cm2. The process includes the steps of slowly trickling whole blood onto one side of a layer composed of the composition of glass fibers, whereby plasma or serum separated from the blood becomes available at another side of the layer. The total volume of the plasma or serum separated from the blood is limited to at most 50% of the absorption volume of the glass fiber layer.
Patent IL-66256-A0 (IL)
Title: Water containing compositions comprising salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
IPC: A61K8/49
Filed: 1982-07-08
Abstract: Alkali metal salts of N-(C1-C5)alkyl- or N-(C1-C5)hydroxyalkyl-2-pyrrolidone-4-carboxylic acids and compositions containing them as humectants, particularly in topical cosmetic and pharmaceutical compositions.
Patent IL-81389-A0 (IL)
Title: Pay-per-view cable television
IPC: H04N7/173
Filed: 1987-01-26
Abstract: A pay-per-view CATV system which is interfaced with the switched public telephone system is described. A subscriber selects a specific scheduled television event by dialing a telephone number which uniquely identifies the selected event. The called and originating numbers are identified, digitized and combined to form a digital word. The digital word is then transmitted to the CATV supplier.
Patent IL-98742-A0 (IL)
Title: Fungicides
IPC: A01N43/42
Filed: 1991-07-05
Abstract: Fungicidal compounds of the formula (I) : <CHEM> and stereoisomers thereof, wherein R<1> is optionally substituted aryl or optionally substituted heteroaryl; Y is oxygen, sulphur or NR<4>; R<2>, R<3> and R<4>, which may be the same or different, are hydrogen, C1-4 alkyl or C2-4 alkenyl; X is halogen, C1-4 alkyl, C2-4 alkenyl, C1-4 alkoxy, nitro or cyano; and n is 0 or an integer of 1 to 4; provided that when Y is oxygen, n is 0 and R<1> is unsubstituted phenyl at least one of R<2> and R<3> is other than hydrogen or methyl.
Patent FI-20041483-A0 (FI)
Inventor: HIRAHARA EDWIN
IPC: A01G9/10
Filed: 2004-11-18
Abstract: A embryo delivery system 20 is composed of an embryo orientation assembly 22 , a transfer assembly 24 , and an embryo reception assembly 26 . In operation, the embryo delivery system 20 retrieves plant embryos one at a time from a position on the manufactured seed production line with microtweezers and places each embryo into a separate growing medium, such as a seed coat. The embryo delivery system 20 further includes a control system 28 having a computer 56 or other general computing device for automating the embryo delivery process.
Patent FI-20065593-A0 (FI)
Inventor: SIBAKOV TIMO
Filed: 2006-09-26
Abstract: The invention relates to a method for production of galactooligosaccharides-containing milk-based products that as a part of a regular diet has beneficial physiological effects, and hence is capable of enhancing colon health and improving gastrointestinal conditions. The invention further relates to a use of the product as such, having laxative or bifidogenic effect, or as prebiotic ingredient for use in the preparation of functional foodproducts.
Patent IL-125458-A0 (IL)
Title: Novel bioluminescent items
IPC: D06Q1/00
Filed: 1997-02-03
Abstract: Novelty items that are combinations of articles of manufacture with fluorescent proteins are provided. These novelty items, include combinations of transgenic plants that express a luciferase or a luciferin with plant food that contains a luciferase and a luciferin.
Patent IL-136773-A0 (IL)
Title: Inhibition of raf kinase aryl and heteroaryl substituted heterocyclic ureas
IPC: A61K31/4427
Filed: 1998-12-22
Abstract: Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
Patent IL-141756-A0 (IL)
Title: Unsaturated hydroximic acid derivatives as parp inhibitors
IPC: A61K31/4427
Filed: 1999-09-02
Abstract: The object of the invention consists of novel unsaturated hydroximic acid derivatives, the process for their preparation and as active substance such as compounds containing pharmaceutical compositions. The novel compounds possess valuable pharmaceutical effects, so they can be used in the treatment of states connected with energy deficiency of the cell caused by PARP inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases. In formula (I).
Patent IL-146756-A0 (IL)
Title: 5-cyano-2-aminopyrimidine derivatives
IPC: C07D401/14
Filed: 2000-06-19
Abstract: Pyrimidines of formula (1) are described wherein Ar is an optionally substituted aromatic or heteroaromatic group; R<1 >is a hydrogen atom or a straight or branched chain alkyl group; R<2 >is a -X<1>-R<3 >group where X<1 >is a direct bond or a linker atom or group, and R<3 >is an optionally substituted aliphatic, cycloaliphatic, heteroaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are selective KDR Kinase and/or FGFr Kinase inhibitors and are of use in the prophylaxis and treatment of disease states assoicated with angiogenesis.
Patent IL-152031-A0 (IL)
Title: Method and installation for the production of a condensed non woven and condenser device
IPC: D01G15/46
Filed: 2002-09-30
Abstract: A primary non-woven web (W1) from a carding machine is transported by a primary belt conveyor (S1) to a rotary cylinder (21). The primary non-woven web is switched to a secondary belt conveyor (S2) by the rotary cylinder. Linear speed of the secondary conveyor is slower than circumferential speed of the rotary cylinder. <??>Independent claims are also included for the following: <??>(1) a condensing device for non-woven web; and <??>(2) a production installation for producing condensed non-woven web.
Patent IL-158777-A0 (IL)
Title: Orally administering parathyroid hormone and calcitonin
IPC: A61P19/08
Filed: 2002-05-31
Abstract: A method for orally administering a parathyroid hormone, PTH, comprising orally co-administering to a patient in need of PTH an effective amount of a PTH and an effective amount of calcitonin. The method according to the invention allows for the oral administration of PTH without the hypercalcemia, hypercalcuria and nephrolithiasis side effects.
Patent IL-173305-A0 (IL)
Title: Matrix metalloproteinase inhibitors
IPC: A61P29/00
Filed: 2006-01-23
Abstract: Compounds of Formula (I):   
Wherein: A represents bond, C 1-6 alkyl or CH=CH-C 1-4 alkyl; 
B represents bond, O, S, SO, SO 2 , CO, CR 7 R 8 , CO 2 R 14 , CONR 14 R 15 , N(COR 14 )(COR 15 ), 
N(SO 2 R 14 )(COR 15 ) or NR 14 R 15 ; 
D represents bond, or C 1-6 alkyl; 
E represents substituted aryl or substituted or unsubstituted heteroaryl; 
Q represents an optionally substituted 5- or 6-membered aryl or heteroaryl ring; 
X represents O, S, SO, SO 2 , CO, CNR 5 , CNOR 5 , CNNR 5 R 6 , NR 11  or CR 7 R 8 ; 
Y represents CR 5 OR 11 , CR 5 SR 11 , NOR 5 , CR 5 NR 6 R 11 , SO, SO 2 , CO, CNR 5 , CNOR 5  or CS; 
R 1  and R 1'  each independently represents H, C 1-6 alkyl or C 1-4 alkylaryl; 
R 2  represents CO 2 R 12 , CH 2 OR 12  or CONR 12 R 13 , CONR 12 OR 13 , NR 12 COR 13 , SR 12 , PO(OH) 2 , 
PONHR 12  or SONHR 12 ; 
R 3  represents H, C 1-6 alkyl or C 1-4 alkylaryl; 
R 4  represents optionally substituted aryl or heteroaryl; 
Z represents a bond, CH 2 , O, S, SO, SO 2 , NR 5  , OCR 5 R 6 , CR 9 R 10 O or Z, R 4  and Q together form an optionally substituted fused tricyclic group; 
R 5  and R 6  each independently represent H, C 1-6  alkyl or C 1-4  alkylaryl; 
R 7  and R 8  each independently represent H, halo, C 1-6  alkyl or C 1-4  alkylaryl; 
R 9  and R 10  each independently represents H, C 1-6  alkyl optionally substituted by halo, cyano, 
OR 11  or NR 6 R 11 , C 1-4  alkylaryl optionally substituted by halo, cyano, OR11 or NR 6 R 11 , OR 11  or, together with the N to which they are attached, R 9  and R 10  form a heterocyclic group: 
R 11  represents H, C 1-6  alkyl, C 1-4 alkylaryl or COR 5 ; 
R 12  and R 13  each independently represent H, C 1-3  alkyl, C 1-3 alkylaryl or C 1-3  alkylheteroaryl or, together with the functionality to which they are attached, R 12  and R 13  form a heterocyclic group: 
R 14  and R 15  each independently represent H, C 1-6  alkyl, C 1-4  alkylaryl or C 1-4  alkylheteroaryl or together with the functionality to which they are attached R 14  and R 15  form a heterocyclic or fused heterocyclic group: and physiologically functional derivatives thereof, processes for their preparation, pharmaceutical formulations containing them and their use as inhibitors of matrix metallproteinase enzymes (MMPs) are described.
Patent IL-175358-A0 (IL)
Title: 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
IPC: A61K31/4439
Filed: 2006-05-01
Abstract: The present invention provides certain substituted 1,4-dihydropyridine compounds, including pure enantiomeric forms and pharmaceutical formulations thereof. These compounds provide for elevation of alpha-MyHC protein levels and alpha-MyHC mRNA levels, and most frequently these same compounds provide simultaneous lowering of beta-MyHC protein levels and beta-MyHC mRNA levels. Thus, these compounds may be used alone or in conjunction with other drugs to treat heart failure.
Patent IL-185863-A0 (IL)
Title: Dyed polyolefin yarn and textile fabrics using such yarns
IPC: D06M13/203
Filed: 2007-09-10
Abstract: A novel polyolefin textile fabric knitted woven and non-woven that in one aspect of the invention is disperse dyed to a light, medium or deep solid shade. In another aspect, the textile fabrics of the present invention are manufactured using polyolefin yarns that contain variable amounts of dye acceptor additives. A fabric with more than one tone of a color is dyed in a single dye bath. The fabrics and yarn using this invention can be processed using conventional spinning, weaving, knitting, web forming machines and will dye using existing dyeing and finishing systems. This invention is of particular value in the apparel and home furnishings industry.
Patent IL-190919-A0 (IL)
Title: Solar power system with a number of photovoltaic modules
Filed: 2008-04-17
Abstract: The system has mounting supports (50), and photovoltaic modules that are mounted on the supports. Retaining units (100) are provided for retaining the modules on the supports, and double bridges (60) comprise electrically contacting connecting plugs that are plugged together with the mounting movement of the modules. The modules are enclosed by a holding frame (10) that is made from plastic, and a mechanical connection unit and the connecting plugs are integrated in the holding frame, where the mechanical connection unit interacts with the retaining units in a positive manner.
Patent RO-125497-A0 (RO)
Title: Method and device for rehabilitating therapeutical properties of the water from balneation layer in salt lakes with layered concentration
Inventor: NEDERIŢĂ VICTOR
IPC: F03G7/05
Filed: 2009-05-05
Abstract: The invention relates to a method and an apparatus for rehabilitating the therapeutical properties of the water from the balneation layer in salt lakes with layered concentration. According to the invention, the method consists in introducing, in continuous flux, the surface water from the balneation layer under the water level with high salt concentration by free gravitational falling, the mixing, transporting and diffusing the rehabilitated water mixture in the surface area of the balneation layer by direct osmosis. According to the invention, the apparatus for carrying out the method consists of one or more intercommunicable recipients (1) inter-connected by means of one or more mixing chambers (3) and separated by some semi-permeable membranes or/and some membranes (4) with selective permeability, the feeding of the mixing chamber/chambers (3) with polluted water from the surface being performed by immersing the ends of the feeding intercommunicable recipients (1) under the level (A) of the surface water and the feeding with saturated brine being performed through the low end of the intercommunicable recipient (1) of discharging the rehabilitated mixture towards the surface.
Patent RO-126692-A0 (RO)
Title: Braking system in hydraulic displacement motors
Inventor: STAN GHEORGHE
IPC: F03C1/26
Filed: 2011-05-25
Abstract: The invention relates to a braking system for hydraulic displacement motors employed to displace high-inertia mobile elements. According to the invention, the system comprises at each end a braking chamber (C) and a safety valve (S), where, upon a piston (1) passing from high speed (V) to low speed (V), within the braking chamber (C) there takes place a compression whose value is limited by a safety valve (S) consisting of a body (9), a ball (11), a helical spring (13) and an adjusting screw (14), the safety valve (S) being placed in each of the flanges (2 and 3) so that the passing from the high speed (V) to the low speed (V) is free of discontinuities and shaking, irrespective of the ratio between the speeds (Vand V) and the value of the mobile element integral with the piston (1).
Patent RO-133469-A0 (RO)
Title: Dairy product as frozen dessert based on goat milk and process for preparing the same
Inventor: NISTOR OANA VIORELA
IPC: A23C9/152
Filed: 2018-07-27
Abstract: The invention relates to a process for preparing a dairy product as a frozen dessert. According to the invention, the process consists in preheating to 40...45°C a mixture of 85.5...87% goat milk with the solid components: 2.5% fat, with 2.2% egg yolk as powder, 0.3% agar-agar and, possibly, 1% carob powder, and 1.5% coconut oil, respectively, to result in a basic emulsion which is heated in two stages: at 65...70°C for 3 min, when 1.5% corn starch is added to obtain a gel structure to which 6% agave syrup and 2% rum or vanilla essence are admixed, and at the temperature of 85...90°C for 4 min, in order to pasteurize the mixture, to finally result in a product having a dry matter content of 21.66...22.19% and 2.52...2.91% lipids, 3.49...4.13% proteins, 14.51...15.32% carbohydrates and 0.61...0.76% mineral salts.
Patent AP-2000001820-A0 (AP)
Title: Biostatic coatings for the reduction and prevention of bacterial adhesion.
Inventor: DALLA RIVA TOMA JOAN
IPC: A01N47/36
Filed: 1998-12-08
Abstract: The present invention relates to biostatic compositions, as well as coatings and methods for preparing biostatic articles using the same. The compositions contain a hydrophilic polymer possessing a functional group which covalently bonds to an amine, thiol, carboxyl, or hydrosyl active group of an antimicrobial agent. The functional group is capable of reacting with and covalently bonding to an antimicrobial agent without effectively reducing antimicrobial property of the antimicrobial agent below its capability of acting as a biostatic agent and without releasing the antimicrobial agent into a solution.
Patent AP-2002002419-A0 (AP)
Title: Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
Inventor: STUTZMAN-ENGWALL KIM JONELLE
IPC: A01N43/90
Filed: 2000-07-19
Abstract: The present invention relates to polynucleotide molecules comprising nucleotide sequences encodingan avec gene product, which polynucleotide molecules can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation cultures of s avermitilis.THe present invention further relates to vectors, host cells, and mutant strains of s. Avermitilis in which the avec gene has been inactivated, or mutated so as to change the ratio or amount of class 2:1 avermectins produced.
Patent IE-910424-A1 (IE)
Title: Novel vaccine and method therefor
Inventor: CAPIAU CARINE
IPC: C07K1/113
Filed: 1991-02-08
Abstract: A detoxified B. pertussis toxin or antigenic preparation is described, which is characterized by stability to reversion to toxicity upon storage at 4-8  DEG C and at temperatures above 23  DEG C. Also provided are methods for producing detoxified pertussis toxin and vaccines containing same.
Patent MA-20079-A1 (MA)
Inventor: ISAAC JACOB LEVINE
IPC: C08F10/02
Filed: 1984-03-29
Abstract: Ethylene copolymers having a density of less than 0.91 g/cm<3> and a 1% secant modulus of less than 140,000 kPa are continuously prepared in a fluidized bed without particle agglomeration by continuously contacting, in such fluidized bed, at a temperature of from 10 DEG C up to 80 DEG C, a gaseous mixture containing (a) ethylene and at least one higher alph olefin in a molar ratio of such higher alpha olefin to ethylene of from 0.35:1 to 8.0:1, and (b) at least 25 mol percent of a diluent gas, with a catalyst composition prepared by forming a precursor composition from a magnesium compound, titanium compound, and electron donor compound; diluting said precursor composition with an inert carrier; and activating the diluted precursor composition with an organoaluminum compound.
Patent MA-22206-A1 (MA)
Inventor: FEUCHT D
IPC: A01N25/14
Filed: 1991-07-05
Abstract: The invention relates to novel ready-for-use formulations of the known herbicidal active substances metamitron (I) + ethofumesate (II) +  (A) phenmedipham (III) or  (B) phenmedipham (III) and desmedipham (IV) or  (C) desmidipham (IV), preferably solid formulations such as water-dispersible powders (WP) or water-dispersible granules (WG), the ratio by weight of the active substances (I):(II):(III) or (IV) being (1):(0.05 to 1):(0.05 to 1), that of the active substances (I):(II):(III):(IV) being (1):(0.05 to 1):(0.05 to 1):(0.05 to 1), and the total active substance content in each case being between 20 and 75% by weight, and to their use as herbicides, in particular as selective herbicides in beet.
Patent MA-39545-A1 (MA)
Title: Procédé et installation de traitement d'un mélange de déchets a deux cycles de compostage
Inventor: CHARREYRE FABIEN MICHEL ALAIN
IPC: C05F17/02
Filed: 2015-05-23
Abstract: - l'invention concerne une installation et un procédé de traitement d'un mélange de déchets (4) comprenant des déchets biodégradables, le procédé étant caractérisé en ce qu'il comporte les étapes successives suivantes : - étape a : on fait subir un premier cycle de compostage au mélange de déchets (4) de manière à obtenir un mélange de déchets (4) pré-compostés, - étape b : on fait subir un séchage au mélange de déchets (4) pré-compostés pour obtenir un mélange de déchets (4) séchés, - étape c : on sépare le mélange de déchets (4) séchés en au moins une portion de déchets lourds (14) et une portion de déchets légers (13), - étape d : on fait subir un deuxième cycle de compostage à la portion de déchets légers (13) de manière à obtenir un mélange de déchets (4) affinés (20). - traitement des déchets biodégradables.